According to Biotest 's latest financial reports the company's current earnings are A$0.77 Billion. In 2023 the company made an earning of A$0.24 Billion, an increase over its 2022 earnings that were of -A$18.08 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | A$0.14 B | -40.57% |
2023 | A$0.24 B | -1455.72% |
2022 | -A$18.08 Million | -79.44% |
2021 | -A$87.92 Million | 359.41% |
2020 | -A$19.14 Million | -213.86% |
2019 | A$16.8 M | -20.6% |
2018 | A$21.16 M | -135.69% |
2017 | -A$59.32 Million | -139.86% |
2016 | A$0.14 B | -227.25% |
2015 | -A$0.12 Billion | -199.09% |
2014 | A$0.11 B | 5.24% |
2013 | A$0.11 B | 29.54% |
2012 | A$86.55 M | -35.34% |
2011 | A$0.13 B | 28.46% |
2010 | A$0.10 B | -31.44% |
2009 | A$0.15 B |